Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 143, 2023 - Issue 7
Submit an article Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Oncology

The timing and methods for detection of recurrence in patients with head and neck cancer

Satoru MiyamaruDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1008-6904View further author information
ORCID Icon,
Kohei NishimotoDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, JapanView further author information
,
Daizo MurakamiDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, JapanView further author information
,
Kaoruko KuraokaDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, JapanView further author information
,
Haruki SaitoDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, JapanView further author information
&
Yorihisa OritaDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, JapanView further author information
Pages 617-622 | Received 29 Apr 2023, Accepted 11 Jul 2023, Published online: 27 Jul 2023

References

  • Wong LY, Wei WI, Lam LK, et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25(11):953–959. doi: 10.1002/hed.10310.
  • Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18(3):651–658. doi: 10.1200/JCO.2000.18.3.651.
  • Beswick DM, Gooding WE, Johnson JT, et al. Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring. Laryngoscope. 2012;122(7):1512–1517. doi: 10.1002/lary.23341.
  • Flynn CJ, Khaouam N, Gardner S, et al. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol (R Coll Radiol). 2010;22(10):868–873. doi: 10.1016/j.clon.2010.05.016.
  • Kothari P, Trinidade A, Hewitt RJD, et al. The follow-up of patients with head and neck cancer: an analysis of 1039 patients. Eur Arch Otorhinolaryngol. 2011;268(8):1191–1200. doi: 10.1007/s00405-010-1461-2.
  • Lester SE, Wight RG. “When will I see you again?” using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol. 2009;34(6):546–551. doi: 10.1111/j.1749-4486.2009.02033.x.
  • de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg. 1994;120(9):934–939. doi: 10.1001/archotol.1994.01880330022005.
  • Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognositc factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004;15(8):1179–1186. doi: 10.1093/annonc/mdh308.
  • Spector JG, Sessions DG, Lenox J, et al. Management of T3N1 glottic carcinoma: therapeutic outcomes. Laryngoscope. 2006;116(1):106–110. doi: 10.1097/01.mlg.0000184767.62682.3d.
  • Baba D, Fushimi C, Hanyu K, et al. Prognostic factors of potential early recurrence of hypopharyngeal carcinoma. Anticancer Res. 2021;41(11):5761–5766. doi: 10.21873/anticanres.15392.
  • Hosni A, Huang SH, Chiu K, et al. Predictors of early recurrence prior to planned postoperative radiation therapy for oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy. Int J Radiat Oncol Biol Phys. 2019;103(2):363–373. doi: 10.1016/j.ijrobp.2018.09.013.
  • Hudgins PA. Flap reconstruction in the head and neck: expected appearance, complications, and recurrent disease. Eur J Radiol. 2002;44(2):130–138. doi: 10.1016/s0720-048x(02)00067-0.
  • Gore A, Baugnon K, Beitler J, et al. Posttreatment imaging in patients with head and neck cancer without clinical evidence of recurrence: should surveillance imaging extend beyond 6 months? AJNR Am J Neuroradiol. 2020;41(7):1238–1244. doi: 10.3174/ajnr.A6614.
  • Dunsky KA, Wehrmann DJ, Osman MM, et al. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. Laryngoscope. 2013;123(9):2161–2164. doi: 10.1002/lary.23941.
  • Jensen KK, Grønhøj C, Jensen DH, et al. Circulating human papillomavirus DNA as a surveillance tool in head and neck squamous cell carcinoma: a systemic review and meta-analysis. Clin Otolaryngol. 2018;43(5):1242–1249. doi: 10.1111/coa.13136.
  • Peng H, Li Z, Long Y, et al. Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis. Biosci Rep. 2019;39(9):BSR20190691. doi: 10.1042/BSR20190691.
  • Inoue H, Yokota T, Hamauchi S, et al. Pre-treatment tumor size impacts on response to nivolumab in head and neck squamous cell carcinoma. Auris Nasus Larynx. 2020;47(4):650–657. doi: 10.1016/j.anl.2020.01.003.
  • Suzuki C, Kiyota N, Imamura Y, et al. Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer. Int J Clin Oncol. 2020;25(7):1270–1277. doi: 10.1007/s10147-020-01669-y.
  • Matoba T, Minohara K, Kawakita D, et al. Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors. Sci Rep. 2022;12(1):14319. doi: 10.1038/s41598-022-18611-z.
  • Sasaki M, Aoki T, Karakida K, et al. Postoperative follow-up strategy in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg. 2011;69(6):e105–e111. doi: 10.1016/j.joms.2010.11.039.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.